Position in AKBA
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$2,548,047
-$3,236,897 QoQ
Shares Held
1,833,128
-49.0% QoQ
Ownership
0.662%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AKBA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026RENAISSANCE TECHNOLOGIES LLC holds $2,182,136,934 across 49 Drug Manufacturers - Specialty & Generic names. AKBA ranks #26 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
1,787,019 | $1,059,666,526 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
2,418,897 | $318,665,490 | |
| 3 | ALKS |
Alkermes plc.
|
6,160,428 | $217,832,734 | |
| 4 | RDY |
Dr Reddys Laboratories Ltd
|
7,859,728 | $108,857,232 | |
| 5 | SUPN |
Supernus Pharmaceuticals, Inc.
|
1,705,222 | $88,142,925 | |
| 6 | TAK |
Takeda Pharmaceutical Co Ltd
|
2,989,100 | $55,358,132 | |
| 7 | COLL |
Collegium Pharmaceutical, Inc
|
1,469,449 | $48,594,678 | |
| 8 | HIMS |
Hims & Hers Health, Inc.
|
2,118,080 | $43,971,340 |
All Filings in AKBA
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,548,047 | 1,833,128 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $5,784,944 | 3,593,133 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $10,790,944 | 3,952,727 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $15,267,714 | 4,194,427 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $7,691,187 | 4,005,827 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $7,264,701 | 3,823,527 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $4,907,496 | 3,717,800 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $3,993,096 | 3,914,800 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $6,683 | 3,652,100 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $5,926 | 4,779,383 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $3,597 | 3,155,427 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $3,048 | 3,330,727 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $1,310 | 2,338,500 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $1,665 | 2,886,227 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $953,190 | 3,016,427 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $523,251 | 1,482,300 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $720,388 | 1,003,327 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $1,408,041 | 623,027 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $2,735,789 | 949,927 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $6,927,096 | 1,827,730 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $3,623,916 | 1,070,581 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $4,054,195 | 1,447,927 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $176,139 | 70,175 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $1,027,856 | 75,689 | Shares | Sole | 2020-08-13 | |
| No filing history on record for this holder in this stock. | ||||||